Ironwood Pharmaceuticals (IRWD) Operating Expenses (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Operating Expenses across 17 years of filings, most recently posting $33.7 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 15.49% year-over-year to $33.7 million; the TTM figure through Jun 2026 stood at $155.1 million (down 34.03% YoY), while the FY2025 annual figure was $197.6 million, down 23.48% from the prior year.
• Operating Expenses came in at $33.7 million for Q2 2026 at Ironwood Pharmaceuticals, down from $33.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.2 billion in Q2 2023 to a low of $33.7 million in Q2 2026.
• Average Operating Expenses over 5 years is $115.1 million, with a median of $45.3 million recorded in 2023.
• Year-over-year, Operating Expenses jumped 2763.48% in 2023 and slumped 94.17% in 2024.
• Over 5 years, Operating Expenses stood at $38.8 million in 2022, then soared by 105.9% to $80.0 million in 2023, then decreased by 26.15% to $59.1 million in 2024, then sank by 30.73% to $40.9 million in 2025, then decreased by 17.53% to $33.7 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $33.7 million in Q2 2026, $33.9 million in Q1 2026, and $40.9 million in Q4 2025.